Brief: Enveric Biosciences Says Selling Stockholders Are Offering On A Resale Basis An Aggregate Of 4.8 Million Shares Of Common Stock - SEC Filing
29/09/2025 23:13
Sept 29 (Reuters) - Enveric Biosciences Inc ENVB.O: ENVERIC BIOSCIENCES INC: SELLING STOCKHOLDERS ARE OFFERING ON A RESALE BASIS AN AGGREGATE OF 4.8 MILLION SHARES OF COMMON STOCK - SEC FILING Source text: [ID:n0001493152-25-016013] Further company coverage: ENVB.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Enveric Biosciences
See all newsBrief: Enveric Biosciences Announces Positive Results From IND-Enabling ADMET Studies
Enveric Biosciences Q2 net loss widens
AtaiBeckley surges after report Lilly poised to buy psychedelic drug developer
Brief: Enveric Biosciences Initiates Investigational New Drug (IND)-Enabling Genotoxicity Studies Of Lead Neuroplastogen Candidate EB-003
Brief: Enveric Biosciences Reports Positive Preclinical Results From Phototoxicity Analysis For Lead Neuroplastogen Candidate Eb-003